Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Elevated expression of S100A8 and S100A9 correlates with resistance to the BCL-2 inhibitor venetoclax in AML.

× No keyword cloud information.

5 in total

1. S100A8 inhibition in leukemic lymphoblasts induces sensitivity to chemotherapy and inhibition of disease relapse.

Authors: Mohamad Javad Hejazi; Gholamhossein Tamaddon; Narges Kohan; Mohammadreza Sharifi
Journal: Med Oncol Date: 2022-06-08 Impact factor: 3.064

Review 2. The impact of metal availability on immune function during infection.

Authors: Andrew J Monteith; Eric P Skaar
Journal: Trends Endocrinol Metab Date: 2021-09-03 Impact factor: 12.015

3. Gilteritinib-induced upregulation of S100A9 is mediated through BCL6 in acute myeloid leukemia.

Authors: Megan E Zavorka Thomas; Jae Yoon Jeon; Zahra Talebi; Daelynn R Buelow; Josie Silvaroli; Moray J Campbell; Alex Sparreboom; Navjot Pabla; Sharyn D Baker
Journal: Blood Adv Date: 2021-12-14

Review 4. Pathogenic Roles of S100A8 and S100A9 Proteins in Acute Myeloid and Lymphoid Leukemia: Clinical and Therapeutic Impacts.

Authors: Julie Mondet; Simon Chevalier; Pascal Mossuz
Journal: Molecules Date: 2021-03-02 Impact factor: 4.411

5. Bayesian multi-source regression and monocyte-associated gene expression predict BCL-2 inhibitor resistance in acute myeloid leukemia.

Authors: Brian S White; Suleiman A Khan; Mike J Mason; Muhammad Ammad-Ud-Din; Swapnil Potdar; Disha Malani; Heikki Kuusanmäki; Brian J Druker; Caroline Heckman; Olli Kallioniemi; Stephen E Kurtz; Kimmo Porkka; Cristina E Tognon; Jeffrey W Tyner; Tero Aittokallio; Krister Wennerberg; Justin Guinney
Journal: NPJ Precis Oncol Date: 2021-07-23

5 in total